文献速递甲状腺疾病

DNA甲基化单倍型块标记可有效区分滤泡性甲状腺癌与滤泡性腺瘤

DNA Methylation Haplotype Block Markers Efficiently Discriminate Follicular Thyroid Carcinoma from Follicular Adenoma.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

研究利用简化代表性亚硫酸氢盐测序和甲基化单倍型块分析,在33例滤泡性甲状腺癌(FTC)和33例滤泡性腺瘤(FA)样本中筛选差异DNA甲基化标记,构建随机森林模型并在独立验证队列(13例FTC和13例FA)中评估,曲线下面积达0.994。模型对36例恶性潜能不确定的甲状腺肿瘤(TT-UMP)样本评分显示,驱动突变较少的样本评分也较低。

要点

  • DNA甲基化标记可高精度区分FTC与FA,验证队列AUC为0.994。
  • 模型可用于辅助评估TT-UMP的恶性潜能,评分与驱动突变数量相关。
  • 近半数差异甲基化标记位于启动子区,相关基因功能富集于DNA结合。

核心结论

  • 基于DNA甲基化标记构建的FTC预测模型能以高准确度区分FA与FTC组织。
  • 该模型还可用于辅助判断TT-UMP的恶性潜能。

研究设计与样本

  • 使用简化代表性亚硫酸氢盐测序和甲基化单倍型块分析,在33例FTC和33例FA样本中研究DNA甲基化模式。
  • 构建预测模型并在独立队列(13例FTC和13例FA)中验证,另用36例TT-UMP样本评估模型。

主要发现

  • 共鉴定出70个在FTC与FA样本间显著差异的DNA甲基化标记,约半数位于启动子区。
  • 标记相关基因的Gene Ontology富集项均与「DNA结合」相关。
  • 随机森林模型在验证队列中区分FTC与FA的曲线下面积为0.994。
  • TT-UMP样本中驱动突变较少的样本模型评分也较低。

关键数值与推荐

  • 验证队列中模型区分FTC与FA的AUC为0.994。

临床怎么用

  • 对于病理鉴别困难的FTC与FA,可考虑DNA甲基化标记辅助诊断。
  • 对TT-UMP样本可借助该模型评分辅助评估恶性潜能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Follicular thyroid carcinoma (FTC) is the second most common type of thyroid carcinoma and must be pathologically distinguished from benign follicular adenoma (FA). Additionally, the clinical assessment of thyroid tumors with uncertain malignant potential (TT-UMP) demands effective indicators. OBJECTIVE: We aimed to identify discriminating DNA methylation markers between FA and FTC. METHODS: DNA methylation patterns were investigated in 33 FTC and 33 FA samples using reduced representation bisulfite sequencing and methylation haplotype block-based analysis. A prediction model was constructed and validated in an independent cohort of 13 FTC and 13 FA samples. Moreover, 36 TT-UMP samples were assessed using this model. RESULTS: A total of 70 DNA methylation markers, approximately half of which were located within promoters, were identified to be significantly different between the FTC and FA samples. All the Gene Ontology terms enriched among the marker-associated genes were related to "DNA binding," implying that the inactivation of DNA binding played a role in FTC development. A random forest model with an area under the curve of 0.994 was constructed using those markers for discriminating FTC from FA in the validation cohort. When the TT-UMP samples were scored using this model, those with fewer driver mutations also exhibited lower scores. CONCLUSION: An FTC-predicting model was constructed using DNA methylation markers, which distinguished between FA and FTC tissues with a high degree of accuracy. This model can also be used to help determine the potential of malignancy in TT-UMP.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Zhang H, Zhang Z, Liu X, et al. DNA Methylation Haplotype Block Markers Efficiently Discriminate Follicular Thyroid Carcinoma from Follicular Adenoma. J Clin Endocrinol Metab. 2021. PMID: 33394038. doi:10.1210/clinem/dgaa950

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。